Skip to main content
. 2012 May 2;8(2):103–110. doi: 10.1007/s11420-012-9275-y

Table 1.

Patient’s characteristics and relevant clinical information

Patient Sex/age (years) BMI (kg/m2) Prodromal pain duration (months) BP (duration in years) Indication Comorbidities Other medications Fracture history Fracture location Radiolucent line Overalla follow-up (months)
1 F/65 26.4 6 Fosamax (5) Osteoporosis Scoliosis, uveitis, breast tumor (radiation) HRT (30 years) Ribs Right shaft 12
2 F/85 31.2 24 Fosamax (15) Osteoporosis History of breast cancer, enchondroma, hypertension Angiotensin converting enzyme inhibitor Rib, humerus Bilateral shaft − Bilaterally 14
3 F/63 37.3 Not available Fosamax (4) Osteoporosis Hypertension Aspirin, Thiazide Bilateral shaft Right: −; left: + 26
4 F/50 18.3 0.5 Actonel (10) Fractures Ehlers–Danlos syndrome Corticosteroid, birth control Ankle, hand, foot, rib Left ST + 6
5 F/65 29.2 5 Fosamax (10) Osteopenia Phlebitis Warfarin Right femur (atypical) Bilateral shaft + Bilaterally 12
6 F/71 21.3 7 Fosamax (17) Osteopenia HRT Left ST + 26
7 F/82 22.5 9 Fosamax (7) Osteoporosis Hypertension, Reflux, history of radiation Omeprazole, nifedipine Left shaft + 10
8 F/59 37.5 8 Fosamax (7) Osteoporosis Breast cancer, hypothyroidism Synthroid, omeprazole Right femur (atypical) Left ST + 36
9 F/63 24.8 12 Fosamax (15) Osteoporosis Hypothyroidism, osteochondroma HRT (14 years), omeprazole Bilateral shaft Right: −; left: + 36
10 F/65 22.7 24 Fosamax (14) Osteoporosis Hypertension Simvastatin, amlodipine Left femur (atypical) Right shaft Yes (anteriorly) 24

aOverall follow-up is the follow-up time since the time of diagnosis of the stress fracture

F female, BMI body mass index, BP bisphosphonate, HRT hormone replacement therapy, ST subtrochanteric